NASDAQ
CERS

Cerus Corporation

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Cerus Corporation Stock Price

Vitals

Today's Low:
$3.4900
Today's High:
$3.7100
Open Price:
$3.6700
52W Low:
$3.27
52W High:
$8.06
Prev. Close:
$3.6900
Volume:
2069980

Company Statistics

Market Cap.:
$0.618 billion
Book Value:
0.428
Revenue TTM:
$0.154 billion
Operating Margin TTM:
-22.5%
Gross Profit TTM:
$0.067 billion
Gross Profit TTM:
$0.067 billion
Profit Margin:
-27.3%
Return on Assets TTM:
-9.89%
Return on Equity TTM:
-52.5%

Company Profile

Cerus Corporation had its IPO on 1997-01-31 under the ticker symbol CERS.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Cerus Corporation has a staff strength of 0 employees.

Stock update

Shares of Cerus Corporation opened at $3.67 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $3.49 - $3.71, and closed at $3.49.

This is a -5.42% slip from the previous day's closing price.

A total volume of 2,069,980 shares were traded at the close of the day’s session.

In the last one week, shares of Cerus Corporation have slipped by -12.75%.

Cerus Corporation's Key Ratios

Cerus Corporation has a market cap of $0.618 billion, indicating a price to book ratio of 8.6 and a price to sales ratio of 4.002.

In the last 12-months Cerus Corporation’s revenue was $0.154 billion with a gross profit of $0.067 billion and an EBITDA of $-0.032 billion. The EBITDA ratio measures Cerus Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cerus Corporation’s operating margin was -22.5% while its return on assets stood at -9.89% with a return of equity of -52.5%.

In Q2, Cerus Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a positive 30.2%.

Cerus Corporation’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-0.287 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cerus Corporation’s profitability.

Cerus Corporation stock is trading at a EV to sales ratio of 3.46 and a EV to EBITDA ratio of -18.94. Its price to sales ratio in the trailing 12-months stood at 4.002.

Cerus Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Cerus Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Cerus Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Cerus Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Cerus Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Cerus Corporation paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$3.49
52-Week High
$8.06
52-Week Low
$3.27
Analyst Target Price
$9.1

Cerus Corporation stock is currently trading at $3.49 per share. It touched a 52-week high of $8.06 and a 52-week low of $8.06. Analysts tracking the stock have a 12-month average target price of $9.1.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Cerus Corporation

The stock symbol (also called stock or share ticker) of Cerus Corporation is CERS

The IPO of Cerus Corporation took place on 1997-01-31

Similar Industry Stocks (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Last Price
Chg
Chg%
Glaukos Corp (GKOS)
$53.41
-1.17
-2.14%
$2.03
0.14
+7.41%
$283.59
-8.46
-2.9%
3M Company (MMM)
$122.86
-2.44
-1.95%
$0.69
0.01
+1.47%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.

Address

1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, US